Galera Therapeutics, Inc. (GRTX)
0.10
0.00 (0.00%)
USD |
OTCM |
May 08, 16:00
Galera Therapeutics EPS Diluted (Quarterly) : 2.026 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| XOMA Royalty Corp. | 0.2586 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Amgen, Inc. | 3.344 |
| Savara, Inc. | -0.1341 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 153.10M |
| Total Expenses (Quarterly) | -153.10M |
| Enterprise Value | 3.748M |
| Earnings Yield | 1.98K% |
| Normalized Earnings Yield | 551.10 |